Evaluation of EU-approved biofungicides and biovirucides (Clonostachys rosea, Verticillium albo-atrum, Bacillus subtilis, PepMV CH2-1906, lecithins, clove oil) against major tomato pathogens including Fusarium oxysporum, Alternaria spp., and emerging viruses ToLCNDV and ToBRFV, reducing chemical inputs and supporting sustainable plant protection.
This research addresses the urgent need for sustainable plant protection in tomato cultivation by evaluating EU-approved biopesticides against some of the most devastating fungal and viral pathogens affecting tomato crops. The work targets Fusarium oxysporum, Alternaria spp., Verticillium albo-atrum, Tomato leaf curl New Delhi virus (ToLCNDV), and Tomato brown rugose fruit virus (ToBRFV), with the goal of reducing dependence on chemical pesticides. Prior evidence in related pathosystems has shown 35–70% disease reduction using similar biocontrol agents, suggesting strong potential for effective, eco-friendly disease management in tomato production.
Biocontrol agents under evaluation:
Validation approach:
The biopesticides evaluated are already approved for use in the EU, and the underlying biocontrol mechanisms have been validated in related tomato pathosystems with demonstrated efficacy. Current work is at the applied research and validation stage, with in vitro screening and greenhouse in vivo assays completed. Future validation will expand testing to additional Alternaria species and confirm performance under broader greenhouse conditions, advancing toward field-ready integrated pest management recommendations for tomato growers.
Consiglio Nazionale delle Ricerche (CNR) is Italy’s national public research organization, a large multi‑disciplinary network of institutes distributed across the country and coordinated from Rome. Its model places researchers in regional campuses and co‑located laboratories next to universities, hospitals, and industry, enabling rapid collaboration and access to shared core facilities, testbeds, and prototyping. Companies engage through framework agreements, contract research, joint labs, and researcher secondments, with dedicated liaison staff to streamline engagements. Research is supported by competitive funding from the European Commission, Italian national ministries, and regional programs. A technology transfer office advances IP protection, licensing, and spin‑out formation.